Heart-on-a-chip technology predicts preclinical systolic and diastolic in vivo observations for novel cardiac drug in development

NEW YORK, November 18, 2019–TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance. These data will…

UC study estimates mild cognitive impairment among diverse Latino populations at 10%

SACRAMENTO, Calif.) – A study of over 6,300 Latinos of Dominican, Central American, Cuban, Mexican Puerto Rican and South American heritage estimates that nearly 10% of middle-age and older Latinos in the U.S. meet the criteria for mild cognitive impairment.…

Disparities in care, mortality among hospitalized homeless adults with cardiovascular conditions

What The Study Did: Disparities in hospital care as measured by procedure rates and in-hospital death rates between homeless and nonhomeless adults hospitalized for cardiovascular conditions in New York, Massachusetts and Florida were examined in this observational analysis. To access…

Heart-on-a-chip technology predicts preclinical systolic and diastolic in vivo observations for novel cardiac drug in development

NEW YORK, November 18, 2019–TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance. These data will…

Disparities in care, mortality among hospitalized homeless adults with cardiovascular conditions

What The Study Did: Disparities in hospital care as measured by procedure rates and in-hospital death rates between homeless and nonhomeless adults hospitalized for cardiovascular conditions in New York, Massachusetts and Florida were examined in this observational analysis. To access…

Teens with Heart Disease Improve Exercise Capacity in Large Clinical Trial

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in pediatric cardiology.

15-year study finds treatment gaps exist for patients with peripheral arterial disease

Peripheral arterial disease (PAD) is a progressive and life-threatening form of atherosclerosis that narrows the arteries serving the legs, arms, chest, and abdominal organs. It affects more than 8.5 million people in the United States, including 10 to 20 percent…

Omega-3 shows protection against heart disease-related death, without prostate cancer risk

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why…

Researchers discover new mutations in gene associated with disease that causes the heart to weaken

Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood…

Randomized trial at music festival shows potential of virtual reality for CPR training

Cardiologists at Radboud university medical center performed a research project during a large music festival called Lowlands, in the Netherlands in August 2019. The first results of this innovative study are now published in JAMA Cardiology.

Intermittent fasting increases longevity in cardiac catheterization patients

While Intermittent fasting may sound like another dieting craze, the practice of routinely not eating and drinking for short periods of time has shown again to lead to potentially better health outcomes. In a new study by researchers at the…

‘Nudging’ heart patients to take their statins leads to better adherence and better outcomes

Statins are an effective medication for treating patients with heart disease – they cut the risk of a second major adverse cardiac event by almost 50 percent. But only about six percent of patients take statins as prescribed. One way…

‘Nudging’ heart patients to take their statins leads to better adherence and better outcomes

Statins are an effective medication for treating patients with heart disease – they cut the risk of a second major adverse cardiac event by almost 50 percent. But only about six percent of patients take statins as prescribed. One way…

Artificial Intelligence Tool Predicts Life Expectancy in Heart Failure Patients

Researchers at University of California San Diego School of Medicine, as well as a diverse team of cardiologists and physicists, developed a machine learning algorithm to predict the life expectancy in heart failure patients.